Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Medicine|August 5, 2025
A case report on the postoperative management of phyllodes tumor of the breast and literature reviewYuge Ran, Fei Li, Shuai Qie
Frontiers in Oncology|August 7, 2025
Machine learning-driven prognostic prediction model for composite small cell lung cancer: identifying risk factors with network tools and validation using SEER data and external cohortsFei Li, Mengfan Zhao, Linlin Cao, et al.
Frontiers in Immunology|June 18, 2026
Predicting response to immunochemotherapy in EGFR-mutant lung adenocarcinoma after third-generation TKI resistance using CT radiomics-based habitat imagingShuai Qie, Yasong Shi, Jingyun Li, et al.
Frontiers in Immunology|August 1, 2026
Predicting response to immune checkpoint inhibitor plus chemotherapy in EGFR-mutant lung adenocarcinoma following first-generation TKI resistance: a multicenter deep learning studyShuai Qie, Yasong Shi, Jingyun Li, et al.
Medicine|January 5, 2019
Conventionally fractionated stereotactic radiotherapy (CFRT) in combination with dose-dense temozolomide (TMZ) in relapsed malignant glioma: A case reportShuai Qie, Lanhui Yuan, Hong-Yun Shi, et al.
Medicine|December 19, 2018
S-1 plus cisplatin with concurrent radiotherapy for stage III non-small cell lung cancer: A meta-analysis (PRISMA) of randomized control trialsShuai Qie, Yanhong Li, Hong-Yun Shi, et al.
Medicine|September 10, 2022
The benefit of radiotherapy in distant metastatic small-cell lung cancer: A retrospective study based on propensity score matching (PSM)Shuai Qie, Hongyun Shi, Fang Wang, et al.
Medicine|March 24, 2025
Model development and validation for predicting small-cell lung cancer bone metastasis utilizing diverse machine learning algorithms based on the SEER databaseShuai Qie, Xin Zhang, Jiusong Luan, et al.
Discover Oncology|May 20, 2026
A case report of carotid body tumor with rare thoracic vertebral metastasis and literature reviewFei Li, Jie Yang, Juan Zhang, et al.
Medicine|July 27, 2017
S-1 monotherapy versus S-1 combination therapy in gemcitabine-refractory advanced pancreatic cancer: A meta-analysis (PRISMA) of randomized control trialsSheng Zhong, Shuai Qie, Liu Yang, et al.
Pageof 3